252 related articles for article (PubMed ID: 23908125)
1. Effect of acarbose to delay progression of carotid intima-media thickness in early diabetes.
Patel YR; Kirkman MS; Considine RV; Hannon TS; Mather KJ
Diabetes Metab Res Rev; 2013 Oct; 29(7):582-91. PubMed ID: 23908125
[TBL] [Abstract][Full Text] [Related]
2. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance.
Hanefeld M; Chiasson JL; Koehler C; Henkel E; Schaper F; Temelkova-Kurktschiev T
Stroke; 2004 May; 35(5):1073-8. PubMed ID: 15073402
[TBL] [Abstract][Full Text] [Related]
3. Impact of acarbose on carotid intima-media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: A one-year, prospective, randomized, open-label, parallel-group study in Japanese adults with established coronary artery disease.
Koyasu M; Ishii H; Watarai M; Takemoto K; Inden Y; Takeshita K; Amano T; Yoshikawa D; Matsubara T; Murohara T
Clin Ther; 2010 Aug; 32(9):1610-7. PubMed ID: 20974318
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study.
Tanaka A; Murohara T; Taguchi I; Eguchi K; Suzuki M; Kitakaze M; Sato Y; Ishizu T; Higashi Y; Yamada H; Nanasato M; Shimabukuro M; Teragawa H; Ueda S; Kodera S; Matsuhisa M; Kadokami T; Kario K; Nishio Y; Inoue T; Maemura K; Oyama J; Ohishi M; Sata M; Tomiyama H; Node K;
Cardiovasc Diabetol; 2016 Sep; 15(1):133. PubMed ID: 27619983
[TBL] [Abstract][Full Text] [Related]
5. Treatment of impaired glucose tolerance with acarbose and its effect on intima-media thickness: a substudy of the STOP-NIDDM trial (study to prevent non-insulin-dependent diabetes mellitus).
Hanefeld M
Endocr Pract; 2006; 12 Suppl 1():56-9. PubMed ID: 16627382
[TBL] [Abstract][Full Text] [Related]
6. The level of 2-h post-challenge glucose is an independent risk factor of carotid intima-media thickness progression in Korean type 2 diabetic patients.
Kim HJ; Ahn CW; Kang ES; Myoung SM; Cha BS; Won YJ; Lim SK; Kim KR; Huh KB; Lee HC
J Diabetes Complications; 2007; 21(1):7-12. PubMed ID: 17189868
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study.
Hedblad B; Zambanini A; Nilsson P; Janzon L; Berglund G
J Intern Med; 2007 Mar; 261(3):293-305. PubMed ID: 17305652
[TBL] [Abstract][Full Text] [Related]
8. Postchallenge plasma glucose excursions, carotid intima-media thickness, and risk factors for atherosclerosis in Chinese population with type 2 diabetes.
Hu Y; Liu W; Huang R; Zhang X
Atherosclerosis; 2010 May; 210(1):302-6. PubMed ID: 20005514
[TBL] [Abstract][Full Text] [Related]
9. Effect of cilostazol on carotid intima-media thickness in type 2 diabetic patients without cardiovascular event.
Huh JH; Seok H; Lee BW; Kang ES; Lee HC; Cha BS
Endocrine; 2014 Sep; 47(1):138-45. PubMed ID: 24381128
[TBL] [Abstract][Full Text] [Related]
10. Effect of acarbose, an alpha-glucosidase inhibitor, on serum lipoprotein lipase mass levels and common carotid artery intima-media thickness in type 2 diabetes mellitus treated by sulfonylurea.
Oyama T; Saiki A; Endoh K; Ban N; Nagayama D; Ohhira M; Koide N; Miyashita Y; Shirai K
J Atheroscler Thromb; 2008 Jun; 15(3):154-9. PubMed ID: 18603822
[TBL] [Abstract][Full Text] [Related]
11. Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes.
Mita T; Watada H; Ogihara T; Nomiyama T; Ogawa O; Kinoshita J; Shimizu T; Hirose T; Tanaka Y; Kawamori R
Atherosclerosis; 2007 Mar; 191(1):162-7. PubMed ID: 16616147
[TBL] [Abstract][Full Text] [Related]
12. Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study.
Kozakova M; Natali A; Dekker J; Beck-Nielsen H; Laakso M; Nilsson P; Balkau B; Ferrannini E;
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1409-17. PubMed ID: 23599442
[TBL] [Abstract][Full Text] [Related]
13. Association between markers of glycemia and carotid intima-media thickness: the MARK study.
Gomez-Marcos MA; Gomez-Sanchez L; Patino-Alonso MC; Recio-Rodriguez JI; Regalado NG; Ramos R; Marti R; Agudo-Conde C; Rodriguez-Sanchez E; Maderuelo-Fernandez JA; Garcia-Ortiz L;
BMC Cardiovasc Disord; 2016 Oct; 16(1):203. PubMed ID: 27793100
[TBL] [Abstract][Full Text] [Related]
14. Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes.
Hanefeld M; Koehler C; Henkel E; Fuecker K; Schaper F; Temelkova-Kurktschiev T
Diabet Med; 2000 Dec; 17(12):835-40. PubMed ID: 11168325
[TBL] [Abstract][Full Text] [Related]
15. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial.
Mita T; Katakami N; Shiraiwa T; Yoshii H; Onuma T; Kuribayashi N; Osonoi T; Kaneto H; Kosugi K; Umayahara Y; Yamamoto T; Matsumoto K; Yokoyama H; Tsugawa M; Gosho M; Shimomura I; Watada H;
Diabetes Care; 2016 Mar; 39(3):455-64. PubMed ID: 26822324
[TBL] [Abstract][Full Text] [Related]
16. Associations of continuous glucose monitoring-assessed glucose variability with intima-media thickness and ultrasonic tissue characteristics of the carotid arteries: a cross-sectional analysis in patients with type 2 diabetes.
Taya N; Katakami N; Mita T; Okada Y; Wakasugi S; Yoshii H; Shiraiwa T; Otsuka A; Umayahara Y; Ryomoto K; Hatazaki M; Yasuda T; Yamamoto T; Gosho M; Shimomura I; Watada H
Cardiovasc Diabetol; 2021 May; 20(1):95. PubMed ID: 33947398
[TBL] [Abstract][Full Text] [Related]
17. Postprandial hypertriglyceridemia and carotid intima-media thickness in north Indian type 2 diabetic subjects.
Ahmad J; Hameed B; Das G; Siddiqui MA; Ahmad I
Diabetes Res Clin Pract; 2005 Aug; 69(2):142-50. PubMed ID: 15955588
[TBL] [Abstract][Full Text] [Related]
18. Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study.
Katakami N; Mita T; Yoshii H; Shiraiwa T; Yasuda T; Okada Y; Torimoto K; Umayahara Y; Kaneto H; Osonoi T; Yamamoto T; Kuribayashi N; Maeda K; Yokoyama H; Kosugi K; Ohtoshi K; Hayashi I; Sumitani S; Tsugawa M; Ryomoto K; Taki H; Nakamura T; Kawashima S; Sato Y; Watada H; Shimomura I;
Cardiovasc Diabetol; 2020 Jul; 19(1):110. PubMed ID: 32646498
[TBL] [Abstract][Full Text] [Related]
19. Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease.
Beishuizen ED; van de Ree MA; Jukema JW; Tamsma JT; van der Vijver JC; Meinders AE; Putter H; Huisman MV
Diabetes Care; 2004 Dec; 27(12):2887-92. PubMed ID: 15562202
[TBL] [Abstract][Full Text] [Related]
20. Dietary quality and carotid intima media thickness in type 1 and type 2 diabetes: Follow-up of a randomised controlled trial.
Petersen KS; Keogh JB; Lister NB; Clifton PM
Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):830-838. PubMed ID: 29853429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
